Encouraging NS-065 Top-Line Data, However, Uptravi’s Global Ramp-Up Remains the Key
We reiterate our “Overweight” rating on the stock after reviewing our model post FY17 (YE Mar-18) earnings. Our rating is subject to Uptravi’s...
136 Views
Nippon Shinyaku Stock up 6% Provides Profit Booking Opportunity
Announcement – Nippon Shinyaku Co Ltd (4516 JP), on May 10, 2018, announced that presentations on NS-065/ NCNP-01 will be given at 2018 New...
82 Views
Nippon Shinyaku FY17 Earnings - First Glance
Nippon Shinyaku Co Ltd (4516 JP) reported FY17 results on May 09, 2018 Brisk global uptake of recently launched Uptravi and Zalutia drove FY17...
83 Views
Japan Pharmaceuticals: FY17e Earnings Preview (II)
Shionogi & Co Ltd (4507 JP) - May 09, 2018FY18e Potential GuidanceHIV franchise continues its growth trajectory, however, genericization of its...
99 Views
Japan Pharmaceuticals: The Week that Was…
Nippon Shinyaku Co Ltd (4516 JP) @ ¥ 8,480 (up ~18% week-to-date) vs. our TP ¥ 8,600. We recommend booking profit at current levels. Takeda...
108 Views